Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-28 Option Award |
2025-01-30 7:33 pm |
N/A 2035-01-28 |
FEMASYS INC | FEMY | Currie Daniel Scott Chief Operating Officer |
229,197 | $0 | 229,197 (Direct) |
View |
2025-01-28 Option Award |
2025-01-30 7:33 pm |
N/A 2035-01-28 |
FEMASYS INC | FEMY | Thomas Christine E Chief Reg & Clinical Officer |
107,372 | $0 | 107,372 (Direct) |
View |
2025-01-28 Option Award |
2025-01-30 7:33 pm |
2025-01-28 2035-01-28 |
FEMASYS INC | FEMY | Elefant Dov Chief Financial Officer |
186,345 | $0 | 186,345 (Direct) |
View |
2025-01-29 Option Award |
2025-01-30 7:33 pm |
N/A 2035-01-29 |
FEMASYS INC | FEMY | Lee-Sepsick Kathy Chief Executive Officer |
442,902 | $0 | 442,902 (Direct) |
View |
2024-07-12 Option Award |
2024-07-15 4:39 pm |
N/A 2034-07-12 |
FEMASYS INC | FEMY | Silverman Joshua Director |
17,600 | $0 | 17,600 (Direct) |
View |
2024-07-12 Option Award |
2024-07-15 4:37 pm |
N/A 2034-07-12 |
FEMASYS INC | FEMY | Larsen Charles Director |
17,600 | $0 | 17,600 (Direct) |
View |
2024-07-12 Option Award |
2024-07-15 4:34 pm |
N/A 2034-07-12 |
FEMASYS INC | FEMY | Milnes Alistair Director |
17,600 | $0 | 17,600 (Direct) |
View |
2024-07-12 Option Award |
2024-07-15 4:33 pm |
N/A 2034-07-12 |
FEMASYS INC | FEMY | Uzialko Edward R Director |
17,600 | $0 | 17,600 (Direct) |
View |
2024-02-12 Option Award |
2024-02-13 9:47 pm |
N/A 2034-02-12 |
FEMASYS INC | FEMY | Spector Richard D. Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2024-02-01 Option Award |
2024-02-02 4:43 pm |
N/A 2034-02-01 |
FEMASYS INC | FEMY | Currie Daniel Scott Chief Operating Officer |
61,900 | $0 | 61,900 (Direct) |
View |
2024-02-01 Option Award |
2024-02-02 4:43 pm |
N/A 2034-02-01 |
FEMASYS INC | FEMY | Elefant Dov Chief Financial Officer |
84,000 | $0 | 84,000 (Direct) |
View |
2024-02-01 Option Award |
2024-02-02 4:42 pm |
N/A 2034-02-01 |
FEMASYS INC | FEMY | Thomas Christine E SVP, Regulatory & Clinical |
32,600 | $0 | 32,600 (Direct) |
View |
2024-02-01 Option Award |
2024-02-02 4:42 pm |
N/A 2034-02-01 |
FEMASYS INC | FEMY | Lee-Sepsick Kathy Chief Executive Officer |
204,900 | $0 | 204,900 (Direct) |
View |
Ownership |
2023-11-28 5:06 pm |
2023-11-21 2025-11-21 |
FEMASYS INC | FEMY | PharmaCyte Biotech Inc. 10% Owner |
0 | $0 | 12,711,864 (Direct) |
View |
2023-11-21 Option Award |
2023-11-22 4:39 pm |
N/A 2033-11-21 |
FEMASYS INC | FEMY | Silverman Joshua Director |
17,000 | $0 | 17,000 (Direct) |
View |
2023-10-10 Option Award |
2023-11-01 9:40 pm |
N/A 2033-10-10 |
FEMASYS INC | FEMY | Thomas Christine E SVP, Regulatory & Clinical |
60,000 | $0 | 60,000 (Direct) |
View |
2023-07-03 Option Award |
2023-07-03 6:00 pm |
N/A 2033-07-03 |
FEMASYS INC | FEMY | Lee-Sepsick Kathy Chief Executive Officer |
542,300 | $0 | 542,300 (Direct) |
View |
2023-07-03 Option Award |
2023-07-03 6:00 pm |
N/A 2033-07-03 |
FEMASYS INC | FEMY | Elefant Dov Chief Financial Officer |
309,900 | $0 | 309,900 (Direct) |
View |
2023-07-03 Option Award |
2023-07-03 6:00 pm |
N/A 2033-07-03 |
FEMASYS INC | FEMY | Currie Daniel Scott Senior VP, Operations |
209,400 | $0 | 209,400 (Direct) |
View |
2023-06-21 Option Award |
2023-06-23 4:15 pm |
N/A 2033-06-21 |
FEMASYS INC | FEMY | Morrissey Anne Director |
8,500 | $0 | 8,500 (Direct) |
View |
2023-06-21 Option Award |
2023-06-23 4:15 pm |
N/A 2033-06-21 |
FEMASYS INC | FEMY | Perrow Wendy Director |
8,500 | $0 | 8,500 (Direct) |
View |
2023-06-21 Option Award |
2023-06-23 4:15 pm |
N/A 2033-06-21 |
FEMASYS INC | FEMY | Larsen Charles Director |
8,500 | $0 | 8,500 (Direct) |
View |
2023-06-21 Option Award |
2023-06-23 4:15 pm |
N/A 2033-06-21 |
FEMASYS INC | FEMY | Uzialko Edward R Director |
8,500 | $0 | 8,500 (Direct) |
View |
2023-06-14 Option Award |
2023-06-16 4:42 pm |
N/A 2033-06-14 |
FEMASYS INC | FEMY | Milnes Alistair Director |
17,000 | $0 | 17,000 (Direct) |
View |
2023-06-14 Option Award |
2023-06-16 4:41 pm |
N/A 2033-06-14 |
FEMASYS INC | FEMY | Kendall Keith J Director |
17,000 | $0 | 17,000 (Direct) |
View |
2022-10-10 Option Award |
2022-10-17 4:48 pm |
N/A 2032-10-10 |
FEMASYS INC | FEMY | Thomas Christine E SVP, Regulatory & Clinical |
50,000 | $0 | 50,000 (Direct) |
View |
2022-06-08 Option Award |
2022-06-10 6:19 pm |
N/A 2032-06-08 |
FEMASYS INC | FEMY | Dyett John Director |
8,500 | $0 | 8,500 (Direct) |
View |
2022-06-08 Option Award |
2022-06-10 6:19 pm |
N/A 2032-06-08 |
FEMASYS INC | FEMY | Perrow Wendy Director |
8,500 | $0 | 25,500 (Direct) |
View |
2022-06-08 Option Award |
2022-06-10 6:19 pm |
N/A 2032-06-08 |
FEMASYS INC | FEMY | Morrissey Anne Director |
8,500 | $0 | 8,500 (Direct) |
View |
2022-06-08 Option Award |
2022-06-10 6:19 pm |
N/A 2032-06-08 |
FEMASYS INC | FEMY | Larsen Charles Director |
8,500 | $0 | 8,500 (Direct) |
View |
2022-06-08 Option Award |
2022-06-10 6:19 pm |
N/A 2032-06-08 |
FEMASYS INC | FEMY | Adams John Q JR Director |
8,500 | $0 | 8,500 (Direct) |
View |
2022-06-08 Option Award |
2022-06-10 6:19 pm |
N/A 2032-06-08 |
FEMASYS INC | FEMY | Uzialko Edward R Director 10% Owner |
8,500 | $0 | 8,500 (Direct) |
View |
2022-02-28 Option Award |
2022-03-01 4:38 pm |
N/A 2032-02-28 |
FEMASYS INC | FEMY | Elefant Dov Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership(A) |
2022-02-24 4:22 pm |
N/A N/A |
FEMASYS INC | FEMY | Larsen Charles Director |
0 | $0 | 13,889 (Direct) |
View |